Evidence map›Paper›PMID 23801791›Full record

ArticleDiabetes care2013

Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.

Boris Draznin, Janice Gilden, Sherita H Golden, Silvio E Inzucchi, PRIDE investigators, David Baldwin, Bruce W Bode, Jeffrey B Boord, Susan S Braithwaite, Enrico Cagliero and 23 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetes care, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2018
    Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. The Endocrine Hospitalist: Enhancing the Quality of Diabetes Care.Journal of diabetes science and technology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors at 4 institutions in 1 country.

Boris DrazninDivision of Endocrinology, Diabetes and Metabolism, University of Colorado School of Medicine, Aurora, Colorado, USA. boris.draznin@ucdenver.edu
Janice Gilden
Sherita H Golden
Silvio E Inzucchi
PRIDE investigators
David Baldwin
Bruce W Bode
Jeffrey B Boord
Susan S Braithwaite
Enrico Cagliero
Kathleen M Dungan
Mercedes Falciglia
M Kathleen Figaro
Irl B Hirsch
David Klonoff
Mary T Korytkowski
Mikhail Kosiborod
Lillian F Lien
Michelle F Magee
Umesh Masharani
Gregory Maynard
Marie E McDonnell
Eti S Moghissi
Neda Rasouli
Daniel J Rubin
Robert J Rushakoff
Archana R Sadhu
Stanley Schwartz
Jane Jeffrie Seley
Guillermo E Umpierrez
Robert A Vigersky
Cecilia C Low
Deborah J Wexler
Johns Hopkins Medicine · USRosalind Franklin University of Medicine and Science · USUniversity of Colorado Denver · USYale University · US

Funding

JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WONDISFORD, FREDRIC E. · 2013 to 2017
$9.7M
NIDDK NIH HHS P30 DK079637
6 · The paper itself

Abstract

Currently patients with diabetes comprise up to 25-30% of the census of adult wards and critical care units in our hospitals. Although evidence suggests that avoidance of hyperglycemia (>180 mg/dL) and hypoglycemia (<70 mg/dL) is beneficial for positive outcomes in the hospitalized patient, much of this evidence remains controversial and at times somewhat contradictory. We have recently formed a consortium for Planning Research in Inpatient Diabetes (PRIDE) with the goal of promoting clinical research in the area of management of hyperglycemia and diabetes in the hospital. In this article, we outline eight aspects of inpatient glucose management in which randomized clinical trials are needed. We refer to four as system-based issues and four as patient-based issues. We urge further progress in the science of inpatient diabetes management. We hope this call to action is supported by the American Diabetes Association, The Endocrine Society, the American Association of Clinical Endocrinologists, the American Heart Association, the European Association for the Study of Diabetes, the International Diabetes Federation, and the Society of Hospital Medicine. Appropriate federal research funding in this area will help ensure high-quality investigations, the results of which will advance the field. Future clinical trials will allow practitioners to develop optimal approaches for the management of hyperglycemia in the hospitalized patient and lessen the economic and human burden of poor glycemic control and its associated complications and comorbidities in the inpatient setting.

Indexed as

AdultBlood GlucoseDiabetes MellitusHumansHyperglycemiaHypoglycemic AgentsInpatientsBlood GlucoseHypoglycemic Agents

Identifiers

PMID23801791
PMCPMC3687296
OpenAlexW2033674753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.